These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 629252)

  • 21. [Hepatotoxicity from erythromycin estolate].
    Saiz Santos S; Montero López L
    Aten Primaria; 1992 Dec; 10(9):1050. PubMed ID: 1467424
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythromycin estolate impairs the mitochondrial and microsomal calcium homeostasis: correlation with hepatotoxicity.
    Richelmi P; Baldi C; Manzo L; Berte F; Martino AP; Mirabelli F; Bellomo G
    Arch Toxicol Suppl; 1984; 7():298-302. PubMed ID: 6595996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V.
    Breese BB; Disney FA; Green JL; Talpey WB
    Clin Pediatr (Phila); 1977 May; 16(5):460-3. PubMed ID: 403044
    [No Abstract]   [Full Text] [Related]  

  • 24. Ilosone update.
    Culp ER
    Am Fam Physician; 1980 Apr; 21(4):23. PubMed ID: 7377065
    [No Abstract]   [Full Text] [Related]  

  • 25. Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases.
    SanFilippo A
    J Pediatr Surg; 1976 Apr; 11(2):177-80. PubMed ID: 1263054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the article of J. Buchanec and V. Kdrajnák: Lesions of the liver during therapy with erythromycin in 3 children].
    Rouzica M; Filipová K
    Cesk Pediatr; 1975 Jan; 30(1-2):71. PubMed ID: 1132045
    [No Abstract]   [Full Text] [Related]  

  • 27. Selection of an oral erythromycin product.
    Fraser DG
    Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity.
    Pari L; Murugan P
    Pharmacol Res; 2004 May; 49(5):481-6. PubMed ID: 14998559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chlorpromazine and erythromycin on bile salt-induced cholestasis in the rat.
    Drew R; Piestly BG
    Pharmacology; 1979; 18(4):202-9. PubMed ID: 572556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythromycin estolate for treatment of pertussis.
    Torre D; Maggiolo F; Quadrelli C; Sampietro C
    Pediatr Infect Dis; 1986; 5(6):719-20. PubMed ID: 3797311
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems.
    Dujovne CA; Salhab AS
    Pharmacology; 1980; 20(6):285-91. PubMed ID: 7403251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case study: Drug interference in clinical chemistry.
    Hansen JL; Swanson LN
    Am J Med Technol; 1981 Mar; 47(3):189-91. PubMed ID: 7223765
    [No Abstract]   [Full Text] [Related]  

  • 33. [Controlled study of the liver-protective effect of cycloxilic acid in a form of iatrogenic liver disease].
    Neuman M; Fluteau G
    Clin Ter; 1978 Nov; 87(3):243-64. PubMed ID: 380876
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of erythromycin base and estolate in gonococcal urethritis.
    Brown ST; Pedersen HB; Holmes KK
    JAMA; 1977 Sep; 238(13):1371-3. PubMed ID: 408522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions.
    Ginsburg CM; McCracken GH; Culbertson MC
    J Pediatr; 1976 Dec; 89(6):1011-3. PubMed ID: 792404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations.
    Ginsburg CM; McCracken GH; Crow SD; Dildy BR; Morchower G; Steinberg JB; Lancaster K
    Am J Dis Child; 1984 Jun; 138(6):536-9. PubMed ID: 6372437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.
    Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K
    Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
    Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
    Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
    Croteau D; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Apr; 32(4):561-5. PubMed ID: 3259856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets.
    DiSanto AR; Tserng KY; Chodos DJ; DeSante KA; Albert KS; Wagner JG
    J Clin Pharmacol; 1980 Jul; 20(7):437-43. PubMed ID: 7430412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.